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In Brief
Using ancient DNA sequences of variola
virus recovered from the mummified
remains of a 17th century child, Duggan
et al. reconstruct the evolutionary history
of smallpox. With the ancient strain, the
genetic diversification of the smallpox
virus is found to be more recent than
previously supposed and concurrent with
the onset of widespread vaccination.td.
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Smallpox holds a unique position in the history of
medicine. It was the first disease for which a vaccine
was developed and remains the only human disease
eradicated by vaccination. Although there have been
claims of smallpox in Egypt, India, and China dating
back millennia [1–4], the timescale of emergence of
the causative agent, variola virus (VARV), and how
it evolved in the context of increasingly widespread
immunization, have proven controversial [4–9]. In
particular, some molecular-clock-based studies
have suggested that key events in VARV evolution
only occurred during the last two centuries [4–6]
and hence in apparent conflict with anecdotal histor-
ical reports, although it is difficult to distinguish
smallpox from other pustular rashes by description
alone. To address these issues, we captured,
sequenced, and reconstructed a draft genome of
an ancient strain of VARV, sampled from a Lithuanian
child mummy dating between 1643 and 1665 and
close to the time of several documented European
epidemics [1, 2, 10]. When compared to vaccinia vi-Current Biology 26, 3407–3412, Decem
This is an open access article undrus, this archival strain contained the same pattern
of gene degradation as 20th century VARVs, indi-
cating that such loss of gene function had occurred
before ca. 1650. Strikingly, the mummy sequence
fell basal to all currently sequenced strains of VARV
on phylogenetic trees. Molecular-clock analyses
revealed a strong clock-like structure and that the
timescale of smallpox evolution is more recent than
often supposed, with the diversification of major viral
lineages only occurring within the 18th and 19th cen-
turies, concomitant with the development of modern
vaccination.
RESULTS AND DISCUSSION
In an attempt to reveal the evolutionary history of smallpox (var-
iola virus, VARV), we sampled the partial mummified remains of
a young child of undetermined sex found within the crypt of the
Dominican Church of the Holy Spirit of Vilnius, Lithuania, with no
associated artifacts or coffin [11, 12] (Figures 1 and S1). As the
bones were covered by soft tissue, it was difficult to obtain a pre-
cise age at death, although it is thought to be between 2 and 4
years [13]. Radiocarbon dating of the sample yielded a 14C ageber 19, 2016 ª 2016 The Authors. Published by Elsevier Ltd. 3407
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. Dominican Church of the Holy Spirit, Vilnius
Left: Lithuania is shaded in yellow, with the red star indicating the city of Vilnius, the location of the Dominican Church of the Holy Spirit where the VD21 specimen
was found and dated to approximately 1654. Dates in black indicate known smallpox outbreaks in nearby countries during the 17th century [1, 2]. Top right: the
Dominican Church of the Holy Spirit in Vilnius, Lithuania. Bottom right: the crypt where the child mummy was located. See also Figure S1 and Table S1.of 250 ± 15 BP, which at 2 SDs calibrates to 1643–1665 AD (rela-
tive probability, p = 0.93) or 1785–1793 (p = 0.07) (Table S1; Fig-
ure S2). The older calibrated age range, which contains the bulk
of the probability density function, agrees with historical sources
that place this during the Russian occupation of 1655–1661 [12],
as well as the reported presence of endemic smallpox within
Lithuania. Our older date is also supported by a Bayesian molec-
ular-clock analysis, which gave mean sampling time estimates
of 1691 and 1665 under constant size and Bayesian skygrid
demographic models, respectively (see the Supplemental
Experimental Procedures for further details).
BLAST analysis of a library, enriched for an unrelated target
(JC polyomavirus), indicated that of 0.03% of the 1.3 million
hits assigned to viruses, 47% (198 reads) were top hits to
VARV. To confirm the presence of this virus, we enriched
the library using a custom in-solution bait set targeting publicly
available strains of VARV and sequenced 845,594 reads (Sup-
plemental Experimental Procedures). We were able to map
43,243 reads to a reference strain of variola (major) virus (India
1967; GenBank: NC_001611.1) and from this reconstructed an
ancient VARV genome at an average of 183 coverage (range
03–603) (Figure 2). Additionally, through de novo assembly,
we reconstructed a draft viral genome that is 187,565 bp in
length and contains all annotated genes found in the VARV refer-
ence sequence (Supplemental Experimental Procedures). We
investigated the synteny in our draft genome by aligning it to
the variola major virus reference genome sequence [15]. This re-
vealed that the genome of VD21 shows nomajor rearrangements3408 Current Biology 26, 3407–3412, December 19, 2016and a strong conservation in gene content and arrangement with
all other VARVs isolated in the 20th century (Figure 2).
Overall, we identified and confirmed a total of 716 nucleotide
substitutions relative to the VARV reference sequence by eye
and using NASP [16] in conjunction with GATK [17], with a mini-
mum of 53 coverage and 0.9 frequency. We also enriched for,
sequenced, and produced a mitochondrial genome at 1933
coverage. The mitochondrial haplogroup of VD21 was H2a5b
(Supplemental Experimental Procedures). Haplogroup H2 and
its descendent lineages are common throughout Europe. The
presence of a common European haplogroup, as well as the
DNA damage profiles and overall fragment length distribution
of the reads mapped to both VARV and the mitochondrial
genome, supports the presence of authentic ancient DNA.
VARV genomes are characterized by the fragmentation of
several genes, such that they are non-functional, even though
their homologs are intact in vaccinia virus (VACV; GenBank:
NC_006998.1) and in other orthopoxviruses [18]. Notably,
VD21 exhibited the same pattern of gene disruption in compari-
son to VACV as more modern strains of VARV, indicating that
the loss of gene function during VARV evolution had occurred
prior to ca. 1650. However, VD21 also carried a number of
additional amino acid substitutions and nonsense or frameshift
mutations that might alter gene function, although this remains
to be determined.
Phylogenetic analysis of VD21 with 42 additional complete
genomes of VARV (Table S2) and the twomost closely related or-
thopoxviruses (camelpox and taterapox) utilized as outgroups
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Figure 2. VARV Genome Reconstructed from VD21
(A) Coverage of reference NC_001611.1 variola (major) virus genome. The inner-most circle (light purple) indicates the full 185,578 bp length of the reference, and
the inner yellow circle depicts GC content across the reference genome with the genomic average of 32.7% indicated by the thin dark ring. The dark-purple ring
indicates the location of annotated genes in the reference. The outer-most ring (dark orange) represents the coverage depth of reads from sample VD21mapped
to the NC_001611.1 reference sequence averaged across 25 bpwindows. Average coveragewas 183 (minimum 03 tomaximum603). The concentric gray lines
represent intervals of 103 coverage. The plot was constructed with Circos [14].
(B) Conservation of genomic sequence between VD21 and the VARV reference genome NC_001611.1. The plot was constructed with Dotter [15].
See also Figure S2.clearly placed our ancient strain basal to all previously
sequenced VARV strains (Figure 3). The divergent phylogenetic
position of VD21 is seemingly similar to that observed in a partial
VARV sequence obtained from a 300-year-old Siberian mummy
[19], although the 718 bp sequence obtained from that sample
provided little phylogenetic resolution (Figure S3). The basal
phylogenetic position of VD21 clearly indicates that the previ-
ously described genetic diversity of VARV, comprising viruses
sampled between 1944 and 1977 [7] and classified into the P-I
and P-II clades [4], originated after ca. 1654.
To determine a more accurate timescale of VARV evolution,
we estimated genome-scale evolutionary rates. An initial regres-
sion of root-to-tip genetic distances against year of sampling
provided clear evidence for clock-like molecular evolution in
VARV (R2 = 0.79). Importantly, strong temporal structure (R2 =
0.80) was also observed when VD21 was excluded from the
regression analysis, indicating that it was not simply the function
of a single ancient sequence and that it characterizes VARV evo-
lution as a whole [4, 6, 20]. Similarly clock-like evolution was
observed using a Bayesian approach, with extensive overlap in
estimates of substitution rates and divergence times under a
range of molecular-clock and demographic models (Figure 3;
Table S3). Under themodel with the narrowest posterior distribu-tion (strict molecular clock and constant population size), the
evolutionary rate of VARV is estimated to be between 7.3 and
9.6 3 106 nucleotide substitutions per site per year (mean of
8.5 3 106 subs/site/year). This is similar to previous estimates
of the evolutionary dynamics of VARV inferred using tip-
date based methods on more modern strains only [4, 6, 20]
and to rates previously estimated in myxomavirus (another
poxvirus) in European rabbits, for which longitudinal sequence
data is available for a sampling period of 50 years [21]. Finally,
we observed overlapping substitution rates (range of credible
intervals of 5.6 to 9.5 3 106 subs/site/year) when VD21 was
excluded from the analysis, further suggesting that our estimates
of the nucleotide substitution rate are robust.
Assuming a strict molecular clock and a constant population
size, we estimate that the VARV strains sampled here (i.e.,
including VD21) share a common ancestor between 1588 and
1645 (or between 1530 and 1654 under a relaxed molecular
clock; see the Supplemental Experimental Procedures for further
details). This date corresponds to a time of global exploration
and colonization that was most likely central to viral dissemina-
tion [22, 23], but before the development of widespread vaccina-
tion that began after Edward Jenner utilized the related cowpox
virus in 1796 (although, importantly, a related process ofCurrent Biology 26, 3407–3412, December 19, 2016 3409
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Figure 3. Evolutionary History of VARV
(A) Maximum-likelihood phylogeny of 43 strains of VARV rooted using homologous sequences from camels (camelpox) and African gerbils (taterapox), which are
the orthopoxviruses most closely related to VARV. All horizontal branch lengths are drawn to a scale of nucleotide substitutions per site, and bootstrap values are
shown for key nodes, with year of sampling shown for the VARV strains. The VD21 strain is shown in red, and the major clades of VARV (P-I and P-II, with the later
the containing alastrim minor strains) are marked.
(B) Posterior probability densities of mean evolutionary rate estimates for VARV under different molecular-clock and coalescent models, possible 14C dates for
VD21 (i.e., ‘‘1789’’ assumes VD21 is from 1789 rather than 1654), and with VD21 excluded (i.e., ‘‘VD21’’) from the analysis (see Table S3 for full results).
(C) Maximum clade credibility tree showing the timescale of VARV evolution inferred under a strict molecular clock and a constant population size, with the VD21
lineage shown in red and the 95% credible intervals for a number of other key divergence events also shown. The date (1796) of the introduction of the cowpox-
based smallpox vaccine by Jenner, which we include as an historical reference point only, is marked by a hatched line, and it is important to note that a process of
smallpox variolation (inoculation) had most likely been in existence for many centuries prior to this.
See also Figure S3 and Tables S2 and S3.‘‘variolation,’’ or inoculation, had been described in the Islamic
world for many centuries, may have been practiced even earlier
in China, and was becoming increasingly widespread in both
England and other localities during the 18th century [1, 24]). Simi-
larly, according to our molecular timeline and previous molecu-
lar-clock analyses [4], the divergence of the P-I and P-II clades
occurred between 1734 and 1793, and hence just prior to the
development of smallpox vaccination (Figure 3). Interestingly,
there is some historical evidence that increasingly widespread
inoculation in England during this period may have converted
smallpox from a disease largely of adults to one of infants [25].
That the P-II viruses are largely associated with West Africa
and the Americas is also compatible with the idea that the diver-3410 Current Biology 26, 3407–3412, December 19, 2016gence of this clade from P-I reflects the movement of people in
the context of the 18th century slave trade [4].
It is also striking that the genetic diversity within the P-I and P-II
clades has a very recent origin, dating to the end of 19th and
the start of 20th century, and hence corresponding to the rise
of global smallpox vaccination. Such a phylogenetic pattern
strongly suggests that both the P-I and P-II clades experienced
a major population bottleneck at this time, most likely leading to
the extinction of several unsampled older lineages. Perhaps of
greatest note is that the lineage leading to the lower-virulence
‘‘alastrimminor’’ strains is only dated to the 19th century (credible
dates of 1855–1885), although few samples are available for
analysis. Whether and how increasing levels of vaccination
impacted the selection pressures acting on virulence evolution
remains uncertain but could be addressed with the acquisition
of additional ancient strains.
Finally, to confirm our molecular-clock dating analyses, we
estimated substitution rates and divergence times using (1) the
lower-density calibrated 14C date of 1785–1793 (mean of 1789)
of VD21 and (2) a dataset excluding VD21 from all analyses
(and hence similar to some datasets used in previous studies
[4, 6]). Importantly, these produced very similar estimates to
those described above, strongly suggesting that our results are
robust (Table S3; Figure 3). For example, the estimated age of
the tree excluding VD21, corresponding to the time of separation
of P-I and P-II, ranges from 1656–1806 (maximum range of cred-
ible intervals across all models; Table S3) and exhibits extensive
overlap with the date estimates for the split when VD21 is pre-
sent. Similarly, although assigning a date of 1789 to VD21 results
in a shallower common ancestry for VARV as a whole (mean
values of 1666–1686), the remaining divergence times are in
accordance with those obtained when VD21 is dated to 1654.
Our characterization of a 17th century mummy strain provides
a key calibration point in the epidemiological history of smallpox.
Clearly, the evolutionary timescale that we infer, with an origin of
the sampled VARV diversity dating to the mid-16th century, is far
more recent than some reports of smallpox symptomology [26,
27]. Although molecular-clock approaches can only estimate
the timescale of the sampled genetic diversity, apparent con-
flicts between molecular timelines and symptomology have pre-
viously led some authors to reject the use of tip-dated methods
to estimate the timescale of smallpox evolution [4]. The most
distinctive physical manifestation of smallpox—the pustular
rash—has supposedly ‘‘definitive’’ reports in 4th century China,
with suggestions that it was present in ancient Egypt and India
over 3,500 years ago [1, 2, 4], although in reality it is difficult to
distinguish smallpox from chickenpox or measles using histori-
cal records alone [26]. Such a discordance between inferredmo-
lecular-clock dates and retrospective analyses suggests that
if they were indeed due to smallpox, these early cases were
caused by virus lineages that were no longer circulating at the
point of eradication in the 1970s. Conversely, others have sug-
gested that there is little compelling evidence for epidemic
and/or virulent (i.e., high-mortality) smallpox in Europe prior to
the 16th century [22], close to our inferred date for the ancestry
of VARV. For example, the bills of mortality, the best-known
mortality records for Europe at that time, provide the first clear
evidence for severe smallpox in London in 1632 [1, 22], shortly
before several major European and western Asian epidemics
took hold and most likely infected the Lithuanian child studied
here [2, 28].
General Conclusions
To fully resolve the timing of smallpox origins, it will be necessary
to determine whether the long branch connecting VARV to the
other orthopoxviruses predominantly represents evolution in
humans or in other mammals. Although it is tempting to use
the evolutionary rates obtained here to date the divergence of
VARV from its animal reservoir, the branch lengths leading to
the camelpox and taterapox strains are markedly longer than
those associated with VARV, such that cross-species transmis-
sion may be associated with a change in evolutionary rates thatwould confound molecular-clock dating, and the host jump to
humans could have occurred at any point along this branch. In
addition, given the increasing number of animal viruses discov-
ered using metagenomic techniques [29], it is possible that
those species currently known to harbor orthopoxvirus are not
the true reservoir species for VARV. These uncertainties notwith-
standing, our data clearly show that the VARV lineages eradi-
cated during the 20th century had only been in existence for
200 years, at a time of rapidly expanding human movement
and population size in the face of increasingly widespread inoc-
ulation and vaccination.
EXPERIMENTAL PROCEDURES
All laboratory work was performed in dedicated ancient DNA facilities that form
part of the McMaster Ancient DNA Centre. We extracted DNA from a 112.5 mg
subsample of soft tissue from VD21, and the resulting extraction was con-
verted into an Illumina sequencing library following amodified protocol and en-
riched for VARV using a modified MYbaits in-solution capture with a custom
VARV bait set (see the Supplemental Experimental Procedures for full details).
The enriched library was then mapped to the reference sequence for variola
(major) virus (India 1967; GenBank: NC_001611.1), generating a VARV-like
genome with an average coverage of 183. We generated a consensus
genome sequence from the reads mapped to sequence NC_001611.1, strictly
retaining bases where there was a minimum of 53 coverage and only identi-
fying variants with a frequency of at least 0.9. We also attempted a de novo as-
sembly of the VD21 VARV genome. The final de novo genome was 187,565 bp
in length, and the de novo consensus sequence has 97.5% identity across the
185,578 bp to the NC_001611.1 reference VARV sequence.
Full methodologies for both the laboratory and analytical procedures are
provided in the Supplemental Experimental Procedures. Ethical approval for
this work was granted by the Hospital District of Helsinki under statement
no. 164/13/03/00/14. Permission to perform and publish the work reported
herein was granted by the World Health Organization’s Advisory Committee
on Variola Virus Research (ACVVR).
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